Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: A prospective study

Journal of Bone and Mineral Metabolism

Volumn 26, Issue 3, 2008, Pages 271-278

  Kuroki, Yasuo ^a   Kaji, Hiroshi ^b   Kawano, Seiji ^c   Kanda, Fumio ^c   Takai, Yutaka ^d   Kajikawa, Michiko ^e   Sugimoto, Toshitsugu ^f  

^a Kobe Century Memorial Hospital   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KOBE UNIVERSITY HOSPITAL   (Japan)

^d University of Kobe   (Japan)

^e YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^f SHIMANE UNIVERSITY FACULTY OF MEDICINE   (Japan)

Author keywords

Biochemical markers of bone metabolism; Glucocorticoid therapy; Glucocorticoid induced osteoporosis; Initial glucocorticoid dose; Prospective study; Short term effects

Indexed keywords

ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; COLLAGEN TYPE 1; CREATININE; GLUCOCORTICOID; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS;

ADULT; ARTICLE; BONE METABOLISM; CALCIUM EXCRETION; CALCIUM METABOLISM; CLINICAL ARTICLE; FEMALE; HORMONAL THERAPY; HUMAN; KINETICS; MALE; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BONE AND BONES; CALCIUM; FEMALE; GLUCOCORTICOIDS; HUMANS; JAPAN; MALE; MIDDLE AGED; OSTEOCALCIN; PARATHYROID HORMONE; PREDNISOLONE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 43549107510     PISSN: 09148779     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00774-007-0821-5     Document Type: Article

References (30)

1. Buttgereit F, Straub RH, Wehling M, Burmester GR (2004) Glucocorticoids in the treatment of rheumatic diseases. Arthritis Rheum 50:3408-3417
2. Tappy L, Randin D, Volleweidr P, Paquot N, Scherrer U, Schniter P, et al (1994) Mechanism of dexamethasone-induced insulin resistance in healthy humans. J Clin Endocrinol Metab 79:1063-1069
3. Vann Staa TP, Leufkens HGM, Abenhaim L, Zhang B, Cooper C (2000) Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000
4. Manolagas SC, Weinstein RS (1999) Developments in the pathogenesis and treatment of steroid-induced osteoporosis. J Bone Miner Res 14:1061-1066
5. Buttgereit F, Wehling M, Burmester GR (1998) A new hypothesis of modular glucocorticoid actions. Steroid treatment of rheumatic diseases revisited. Arthritis Rheum 41:761-767
6. Kuroki Y, Takabayashi C, Nishiyama K, Shimada T, Shiozawa S, Chihara K, Ueba Y (2004) Adrenocorticotropic hormone response to hypoglycemic stress was preserved by a single bedtime 3-mg dose of prednisolone in patients with rheumatoid arthritis. Mod Rheumatol 14:291-295
7. Buttgereit F, da Silva JA, Boers M, Burmester GR, Cutolo M, et al (2002) Standardised nomenclature for glucocorticoid dosages and glucocorticoid treatment regimens: current questions and tentative answers in rheumatology. Ann Rheum Dis 61:718-722
8. Garnero P, Hausherr E, Chaupuy MC, Marcelli C, Grandjean H, et al (1996) Markers of bone resorption predict hip fracture in elderly women: EPIDOS prospective study. J Bone Miner Res 11:1531-1538
9. Garnero P, Sornay-Rendu E, Claustrar B, Delmas PD (2000) Biochemical markers of bone turnover, endogenous hormones and the risk of fracture in postmenopausal women: the OFELY study. J Bone Miner Res 15:1526-1536
10. Korakaki E, Gourgiotis D, Aligizakis A, Manoura A, Hatzidaki E, et al (2007) Levels of bone collagen markers in preterm infants: relation to antenatal glucocorticoid treatment. J Bone Miner Metab 25:172-178
11. Christiansen C, Riis BJ, Rodbro P (1987) Prediction of rapid bone loss in postmenopausal women. Lancet 1(8542):1105-1108
12. Gomez B, Ardakani S, Ju J, Jenkins D, Cerelli MJ, et al (1995) Monoclonal antibody assay for measuring bone-specific alkaline phosphatase activity in serum. Clin Chem 41:1560-1566
13. Blackburn GF, Shah HP, Kenten JH, Leland J, Kamin RA, et al (1991) Electrochemiluminescence detection for development of immunoassay and DNA probe assays for clinical diagnosis. Clin Chem 37:1534-1539
14. Woitage HW, Pecherstorfer M, Li Y, Keck AV, Horn E, et al (1999) Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices. J Bone Miner Res 14:792-801
15. Godschalk MF, Down RW (1988) Effects of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 3:113-115
16. Purummel MF, Wiersinga WM, Lips P, Sanders TB, Sauerwein HP (1991) The course of biochemical parameters of bone turnover during treatment with corticosteroids. J Clin Endocrinol Metab 72:382-386
17. Pearce G, Tabensky A, Dermas PD, et al (1998) Corticosteroidinduced bone loss in men. J Clin Endocrinol Metab 83:801-806
18. Dovio A, Perazzolo L, Osella G, Ventura M, Termine A, et al (2004) Immediate fall of bone formation and transient increase of bone resorption in the course of high-dose, short-term glucocorticoid therapy in young patients with multiple sclerosis. J Clin Endocrinol Metab 89:4923-4928
19. Webster JC, Cidlowski JA (1999) Mechanisms of glucocorticoidreceptor mediated repression of gene expression. Trends Endocrinol Metab 10:396-402
20. Walton RJ, Preston CJ, Russell RCG, Kenis JA (1975) An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease. Clin Chim Acta 63:227-229
21. Weinstein RS, Chen JR, Powers CC, Stewert SA, Landes RD, et al (2002) Promotion of osteoclast survival and antagonism of bisphosphonate induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041-1048
22. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC (1998) Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. J Clin Invest 102:274-282
23. Rubin MR, Bilezikian JP (2002) Clinical review 151. The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: a reexamination of the evidence. J Clin Endocrinol Metab 87:4033-4041
24. Paz-Pacheco E, Fuleihan GE, Leboff MS (1995) Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. J Bone Miner Res 10:1713-718
25. Hattersley AT, Meeran K, Burran J, Hill P, Shiner R (1994) The effect of long-term and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int 54:198-202
26. 3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Endocrinology 125:638-641
27. Lems WF, Gerrits MI, Jacobs JWG, van Vugt RM, van Rijin HJM, Bijlsma JWJ (1996) Changes in markers of bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 55:288-293
28. Frediani B, Falsetti P, Bisogno S, Baldi F, Acciai C, et al (2004) Effects of high dose methylprednisolone pulse therapy on bone mass and biochemical markers of arthritis: a 12-month randomized prospective controlled study. J Rheumatol 31:1083-1087
29. Chaki O, Yoshikata I, Kikuchi R, Nakayama M, Uchiyama Y, et al (2000) The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women. J Bone Miner Res 15:1537-1544
30. Iki M, Kajita E, Dohi Y, Nishino H, Kusaka Y, et al (1996) Age, menopause, bone turnover markers and lumbar bone loss in healthy Japanese women. Maturitas 25:59-67